Lantern Pharma Reports Third Quarter 2021 Financial Results and Operating Highlights
/PRNewswire/ -- Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") platform...
United States David Waldman Igor Astsaturov Nicholas Koulermos Kishorg Bhatia Johns Hopkins University
Source: prnewswire.com